| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10918228 | Radiotherapy and Oncology | 2015 | 6 Pages |
Abstract
The moderate dose volumes represent the predominant cause of morbidity after IMRT. Prospective trials are thus required to investigate new ways of dose distribution within the OAR.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Raphaelle Mouttet-Audouard, Thomas Lacornerie, Emmanuelle Tresch, Andrew Kramar, Florence Le Tinier, Nick Reynaert, Eric Leblanc, Fabrice Narducci, Eric Lartigau, Philippe Nickers,